基于经络脏腑相关理论的针刺治疗慢性持续期哮喘:多中心随机对照试验研究方案
本研究为多中心随机对照试验,计划纳入68例慢性持续期哮喘患者,随机分为肺经组与心经组,比较不同经穴针刺的疗效差异。试验含2周基线期、4周治疗期(12次针刺)及8周随访期,主要结局为哮喘生活质量问卷(AQLQ)。结果将为针刺选穴处方提供证据,并判断是否需开展确证性试验以进一步验证经络脏腑相关理论。
要点
- 比较肺经穴与心经穴针刺治疗慢性持续期哮喘的疗效差异。
- 主要结局为AQLQ,次要结局包括ACT、PEF、FEV1、SAS和SDS。
- 计划纳入68例,随机分两组,含基线期、治疗期和随访期。
核心结论
- 该试验旨在比较肺经穴与心经穴针刺对慢性持续期哮喘的疗效差异,为选穴处方提供证据。
- 结果还将用于判断是否开展确证性试验,以进一步验证经络脏腑相关理论。
研究设计与样本
- 多中心随机对照试验,计划纳入68例慢性持续期哮喘患者,随机分为肺经组和心经组。
- 试验包括2周基线期、4周治疗期(共12次针刺)和8周随访期。
关键数值与推荐
- 主要结局为哮喘生活质量问卷(AQLQ),在基线、随机后第4周、第8周和第12周采集。
- 次要结局包括哮喘控制测试(ACT)、呼气峰流速(PEF)和第一秒用力呼气容积(FEV1)。
- ACT在基线、第4周、第8周和第12周采集;PEF和FEV1在基线和第4周评估。
- 焦虑自评量表(SAS)和抑郁自评量表(SDS)在基线和第4周评估。
临床怎么用
- 若试验证实经穴间疗效差异,可为慢性持续期哮喘的针刺选穴提供依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Acupuncture is effective in symptom and quality of life improvement of chronic asthma, but the efficacy differences between different acupoints are uncertain. In terms of the theory of Meridian-viscera Association, the study aims to investigate the different effectiveness between acupoints in Lung meridian and the acupoints in Heart meridian, so as to provide the evidence to develop a better prescription of the acupuncture treatment of chronic persistent asthma. METHODS: This study is a multicentral randomized controlled trial. A total of 68 chronic persistent asthma patients will be randomly allocated into two groups: the Lung meridian group and the Heart meridian group. This trial will include a 2-week baseline period, a 4-week treatment period with 12 sessions' acupuncture, and an 8-week follow-up period. The primary outcome is the Asthma Quality of Life Questionnaire (AQLQ). Secondary outcomes are the Asthma Control Test (ACT), Peak Expiratory Flow (PEF), and Forced Expiratory Volume in 1 s (FEV1). The AQLQ and ACT will be collected at baseline, week 4, week 8, and week 12 after randomization. PEF, FEV1, the Self-rating Anxiety Scale (SAS), and the Self-rating Depression Scale (SDS) will be assessed at baseline and week 4. DISCUSSION: The results will provide evidence for acupuncture prescription selection and the clinical efficacy improvement. The results of this trial will also be used to determine whether or not a full definitive trial will go ahead, which will further confirm the theory of Meridian-viscera Association. TRIAL REGISTRATION: Chinese Clinical Trial Registry ( http://www.chictr.org.cn/showproj.aspx?proj=43803 ) ChiCTR1900027284. Registered on 7 November 2019.
引用
- Cheng S, Dong X, Lan L, et al. Acupuncture for chronic persistent asthma based on the theory of Meridian-viscera Association: study protocol for a multi-center randomized controlled trial in China. Trials. 2021. PMID: 33407788. doi:10.1186/s13063-020-04844-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。